An adjustable, safe and highly protective live-attenuated SARS-CoV-2 vaccine based on large-scale one-to-stop codon modifications
Martin Beer(Institute of Virology of the Slovak Academy of Sciences), Volker Thiel(University of Bern), Nico Joël Halwe(Friedrich-Loeffler-Institut), Fabien Labroussaa(Université Claude Bernard Lyon 1), Marco P. Alves(University of Bern), Lisa Thomann(University of Bern), Angele Breithaupt(Friedrich-Loeffler-Institut), Sarah Ochsenbein(University of Bern), Llorenç Grau‐Roma(Universitat Autònoma de Barcelona), Kore Schlottau(Friedrich-Loeffler-Institut), Kimberly Schmied(University of Bern), Charaf Benarafa(University of Bern), Vladimir Cmiljanović(PIQUR Therapeutics (Switzerland)), Silvio Steiner(University of Bern), Lea Almeida(University of Bern), Joerg Jores(University of Bern), Adriano Taddeo(University of Bern), Güliz T. Barut(University of Bern), Annika Kratzel(University of Bern), Claudia Wylezich(Friedrich-Loeffler-Institut), Melanie Brügger(University of Bern), Nadine Ebert(University of Bern), Lorenz Ulrich(Friedrich-Loeffler-Institut), Bettina Salome Trüeb(University of Bern), Ann Kathrin Ahrens(Friedrich-Loeffler-Institut), Jacob Schön(Friedrich-Loeffler-Institut), Étori Aguiar Moreira(University of Bern), Christelle Devisme(University of Bern), Inês Berenguer Veiga(University of Bern), Tobias Britzke(Friedrich-Loeffler-Institut), Péter Túrós(University of Bern), Blandina Exteves(University of Bern), Philip V ́kovski, Donata Hoffmann(Friedrich-Loeffler-Institut), H. Stadler(University of Bern), Jenna N. Kelly(University of Bern)
Cited by 0
Related Papers
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
|Nature|2013|2.1k
The evolution of SARS-CoV-2
|Nature Reviews Microbiology|2023|1.2k
Taxonomy of the order Bunyavirales: update 2019
|Archives of Virology|2019|405